Principal Financial Group Inc. Has $3.50 Million Holdings in AVANOS MEDICAL, INC. (NYSE:AVNS)

Principal Financial Group Inc. increased its position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS) by 2.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 244,063 shares of the company’s stock after buying an additional 6,269 shares during the period. Principal Financial Group Inc. owned 0.53% of AVANOS MEDICAL worth $3,497,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. boosted its position in shares of AVANOS MEDICAL by 27.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company’s stock valued at $47,941,000 after acquiring an additional 644,267 shares during the period. Brown Advisory Inc. increased its stake in shares of AVANOS MEDICAL by 12.0% in the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company’s stock valued at $30,329,000 after buying an additional 204,218 shares during the period. D. E. Shaw & Co. Inc. increased its position in AVANOS MEDICAL by 43.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 494,627 shares of the company’s stock valued at $7,874,000 after purchasing an additional 148,902 shares during the period. JPMorgan Chase & Co. increased its position in AVANOS MEDICAL by 189.8% during the 4th quarter. JPMorgan Chase & Co. now owns 201,634 shares of the company’s stock valued at $3,210,000 after purchasing an additional 132,063 shares during the period. Finally, Bridgeway Capital Management LLC boosted its holdings in shares of AVANOS MEDICAL by 87.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 273,251 shares of the company’s stock worth $4,350,000 after buying an additional 127,591 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors and hedge funds.

AVANOS MEDICAL Price Performance

Shares of AVNS opened at $11.65 on Friday. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. The business’s fifty day moving average is $12.35 and its 200 day moving average is $13.90. AVANOS MEDICAL, INC. has a 12-month low of $11.21 and a 12-month high of $25.36. The stock has a market cap of $538.83 million, a P/E ratio of -1.39 and a beta of 1.12.

AVANOS MEDICAL (NYSE:AVNS) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.07. The business had revenue of $167.50 million during the quarter, compared to analyst estimates of $161.75 million. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.22 EPS. Sell-side analysts anticipate that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.

About AVANOS MEDICAL

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.